Dosage guide
Magnesium L-Threonate dosage
Magnesium L-Threonate dosing: typical range, frequency, half-life, onset, routes. Evidence-tiered.
At a glance
- Typical dose
- 2000mg
- Half-life
- 4hr
- Frequency
- 1 to 3 times daily
- Routes
- oral
Protocol
- 1
Measure the dose
Typical Magnesium L-Threonate dose is 2000 mg. Use a weight-based calculator for individual adjustments.
Open tool → - 2
Set the frequency
Administer 1 to 3 times daily. Half-life of 4 hours anchors the dosing interval.
Open tool → - 3
- 4
Monitor for side effects
Watch for: loose stools; mild GI upset; headache (rare); fatigue (rare). Stop or reduce dose if tolerability breaks down.
Why this dose
Proposed to deliver magnesium across the blood-brain barrier more effectively than other oral salts via threonate-related transporters, raising CNS magnesium and modulating NMDA receptor function and synaptic plasticity.
The typical 2000 mg dose is the figure most commonly used in published protocols for Magnesium L-Threonate. Treat the label as a starting point: body weight, training status, sleep, diet, and concurrent medications all shift the effective dose-response curve in real users.
How to administer
Magnesium L-Threonate is administered via the oral route. Oral dosing is straightforward: take with water, with or without food unless specifically noted.
Onset of action runs around 1 hour after administration. Peak effect lands near 2 hours post-dose. Plan the administration window so that peak effect lines up with whatever outcome you are dosing for, whether that is training, sleep, or symptom coverage.
Half-life note: Plasma elemental magnesium half-life similar to other oral forms; differential CNS uptake (if real) manifests over weeks of consistent dosing
Cycling and tolerance
No formal cycling; continuous use is standard
Effects to expect at typical dose
- Distinct magnesium salt designed for blood-brain barrier penetration; not a higher-quality systemic magnesium
- Liu 2010 rodent study: elevated CSF magnesium ~15% and increased hippocampal synaptic density
- Trial portfolio in humans is small and mostly Magtein-funded; cognitive effects are modest where reported
- Typical dose 1500 to 2000 mg/day delivers only ~108 to 144 mg of elemental magnesium
- GI tolerability comparable to other magnesium forms; loose stools in a minority at 2000 mg/day
- Distinct from magnesium glycinate, which is the conventional sleep/anxiety/repletion form
Best-graded outcomes
- B CSF magnesium elevation in rodents : ~15% CSF magnesium increase (Liu 2010) (Aged rats, 1 month dosing).
- B Hippocampal synaptic density in rodents : Increased synaptic markers (Aged rats).
- B GI tolerability : Loose stools in 5 to 10% (Adults at 1500 to 2000 mg/day).
Side effects and interactions
Common side effects
- loose stools
- mild GI upset
- headache (rare)
- fatigue (rare)
Notable interactions
- tetracyclines and fluoroquinolones (moderate): magnesium chelation reduces antibiotic absorption; separate by 2 to 4 hours
- bisphosphonates (moderate): reduced absorption; separate by 2 hours minimum
- muscle relaxants and aminoglycosides (moderate): potentiated neuromuscular blockade at high doses
- antihypertensives (minor): additive blood pressure reduction at high doses
Lists above cover commonly reported and well-characterized items. They are not exhaustive: review the full Magnesium L-Threonate profile and discuss with a clinician familiar with your medication list before starting, particularly if you are on prescription therapy or have a chronic condition.
Regulatory snapshot
- WADA status
- allowed
- DEA / Rx
- OTC supplement (not scheduled)
- Pregnancy
- Standard magnesium safety; Mg-T-specific data limited
- Legal status
- OTC dietary supplement
Do not use if
- severe renal impairment (eGFR below 30)
- hypermagnesemia
- myasthenia gravis (high doses)
- concurrent IV magnesium therapy
Related calculators
Related research